Eudaimonia Asset Management »

Akebia Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.3M 1.5M 3.64
2025-03-31 $3.4M 1.8M 1.92
2024-03-31 $784k 429k 1.83
2020-06-30 $2.7M 202k 13.58
2017-12-31 $2.7M 181k 14.87
2017-09-30 $4.6M 236k 19.67
2017-06-30 $3.2M 223k 14.37
2015-12-31 $4.9M 380k 12.92
2015-09-30 $2.3M 241k 9.66

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Kratos Defense & Security Solutions Common Stock (KTOS)
Sterling Infrastructure Common Stock (STRL)
Primoris Services Corp Common Stock (PRIM)
Rambus Common Stock (RMBS)
IonQ Common Stock (IONQ)
TTM Technologies Common Stock (TTMI)
Advanced Energy Industries Common Stock (AEIS)
Blackrock Funds - Equities ETF (SMIN)
Fabrinet Common Stock (FN)
nLight Common Stock (LASR)
SPX Technologies Common Stock (SPXC)
AeroVironment Common Stock (AVAV)
Bloom Energy Corp Common Stock (BE)
Talen Energy Corp Common Stock (TLN)

View all positions for Eudaimonia Asset Management

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco
Nuveen

View all funds holding Akebia Therapeutics